(Q34146882)

English

MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity

scientific article published on 27 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity (English)

1 reference

Europe PubMed Central

31 July 2017

Propionibacterium acnes

object named as

Propionibacterium acnes

1 reference

based on heuristic

inferred from title

object named as

Ian F Hermans

5

0 references

author name string

Rebecca C Girvan

1

1 reference

Europe PubMed Central

31 July 2017

Deborah A Knight

2

1 reference

Europe PubMed Central

31 July 2017

Chris J O'Loughlin

3

1 reference

Europe PubMed Central

31 July 2017

Colin M Hayman

4

1 reference

Europe PubMed Central

31 July 2017

Gill A Webster

6

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

27 October 2010

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

29

1 reference

Europe PubMed Central

31 July 2017

3

1 reference

Europe PubMed Central

31 July 2017

545-557

1 reference

Europe PubMed Central

31 July 2017

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Innate immune recognition: mechanisms and pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Structure and function of Toll receptors and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Pathogen-derived immunomodulatory molecules: future immunotherapeutics?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Signaling to NF-kappaB by Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Dendritic cells in pathogen recognition and induction of immune responses: a functional genomics approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Gene-based vaccines: recent technical and clinical advances

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Cumulative Toll-Like Receptor Activation in Human Macrophages Treated with Whole Bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Plasmacytoid dendritic cells in immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Links between innate and adaptive immunity via type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Type I interferons promote cross-priming: more functions for old cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Antigen-presentation properties of plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

based on heuristic

inferred from DOI database lookup

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

NK cells at the interface between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Duration, combination and timing: the signal integration model of dendritic cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Microparticle-based technologies for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Suppression of cell-mediated tumour immunity by Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Nod-like receptors: cytosolic watchdogs for immunity against pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Innate immunity minireview series: making biochemical sense of nucleic acid sensors that trigger antiviral innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Quantitative Determination of Carbohydrates With Dreywood's Anthrone Reagent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

T cell receptor antagonist peptides induce positive selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Tumours can act as adjuvants for humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Preservation of amino acids from in situ-produced bacterial cell wall peptidoglycans in northeastern Atlantic continental margin sediments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Route of immunization and the therapeutic impact of recombinant anticancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Nod2-dependent Th2 polarization of antigen-specific immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

IRF-7 is the master regulator of type-I interferon-dependent immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.040

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.10.040

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34146882&oldid=1887159864"